There is a pressing need for detailed knowledge of the range of pathogens, extent of co-infection and clinical impact of reproductive tract infections (RTIs) among pregnant women. We present prevalence and correlates of RTIs (Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Treponema pallidum subspecies pallidum, bacterial vaginosis and vulvovaginal candidiasis) among 699 pregnant women in Papua New Guinea (PNG), with follow up at birth, 1-, 6- and 12-months postpartum.
This first report of M. genitalium in PNG found a high prevalence (12.5%) among pregnant women, decreasing to 6.1% at six months postpartum, with no evidence of macrolide resistance. Most pregnant women (74.1%) had at least one RTI, with a curable current sexually-transmitted infection (STI) detected in 37.7%. Prevalence of other curable STIs (C. trachomatis, N. gonorrhoeae and T. vaginalis) were all high in in pregnancy, with prevalence decreasing immediately postpartum but rising again by 12 months postpartum. Syndromic management missed at least 75% of infections and there was little use of contraception.
Most of these infections are curable if diagnosis is made available and syndromic management alone is insufficient. This high prevalence of disease negatively affects sexual and reproductive health and these findings have important public health implications in PNG and the region.